Dapagliflozin for cardiorenal protection after intensive care unit discharge: a protocol for a randomised controlled trial evaluating dapagliflozin at ICU discharge for cardiorenal protection (DAPA-ICU). - Dépret F; Chousterman B; Roger C; Garnier M; Lalande R; Kerforne T; Rouve E; Lukaszewicz AC; Ouattara A; Merdji H; Turbil E; Bouhemad B; et al. (BMJ open, 2026)